María‐José Moreno

Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

Josep‐María Ribera, Albert Oriol, Mireia Morgades et al. · Journal of Clinical Oncology · 2014 · 251 citations · Full text

Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.

Josep‐María Ribera, Albert Oriol, Concepción Bethencourt et al. · PubMed · 2005 · 167 citations

High‐dose chemotherapy and immunotherapy in adult Burkitt lymphoma

Albert Oriol, Josep‐María Ribera, Juan Bergua et al. · Cancer · 2008 · 126 citations · Full text

Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial

Josep‐María Ribera, Juan-José Ortega, Albert Oriol et al. · Journal of Clinical Oncology · 2006 · 55 citations

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.

Josep‐María Ribera, Juan-José Ortega, Albert Oriol et al. · PubMed · 2002 · 46 citations